mywealthgrid
Overview
Dashboard
My workspace
My PortfolioWatchlistsFollowingScreenersAlertsResearch
Discover
CompaniesSectorsIndicesMutual fundsInstitutional investorsCompareTrade trends
Market updates
ResultsAnnouncementsSearch filingsCalendarUpcoming listings
Sign in to save your work
Sign inSign up
Loading page…
NI

Novartis India Limited

NSE:EVONILEBSE:EVONILE
HealthcarePharmaceuticals & Biotechnology
₹1,568.1
-15.93%11 Nov close
Mkt cap
₹3,873 Cr
Watch Alert Compare
OverviewChartPeersProfit & lossBalance sheetCash flowRatiosShareholdingF&OFund holdersDocumentsEventsAnnouncementsNotes
AnnualQuarterly

Standalone figures · ₹ crore

₹ CrJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
917985819287938488908691
COGS-53-45-45-57-54-49-50-49————
12610711012712211811810961676570
Operating profit (EBITDA)171720112418262427242221
OPM %19.1%21.5%23.4%13.8%26%20.6%27.5%28.5%31.1%26.4%26%22.8%
Depreciation210011111100
Interest010000000010
1217221010101111119910
Profit before tax283241213428353437333030
Tax8915787105108145
Tax %27%27%35.7%31.2%23.6%25.9%27.9%13.5%25.8%25.8%45.7%16.2%
202427152620252928241625
PAT margin %22.4%30.1%31.4%18.1%27.9%23.4%27.4%34.9%31.6%26.8%18.7%27.9%
EPS (₹)8.29.610.8610.48.310.3011.29.86.510.2
Results filing————————Results filing for Jun 2025Results filing for Sep 2025Results filing for Dec 2025Results filing for Mar 2026

vs same quarter last yearJun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue YoY %-25.1%-22.4%+5.5%+6.6%+1.9%+10.6%+10%+3.3%
-5.1%
+3.7%
-7.6%
+8%
PAT YoY %-61.3%+29%+249.1%-41.3%+27%-13.8%-4.2%+99.6%+7.3%+18.7%-36.8%-13.8%